Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes

Journal:

Diabetes Care

Published:

2025-11-21

DOI:

10.2337/dc25-1753

Affiliations:

8

Authors:

167

Go to article

Institutions	Authors	Share
Jaeb Center for Health Research (JCHR), United States of America (USA)	3.000000	0.27
Tandem Diabetes Care, Inc., United States of America (USA)	2.000000	0.18
McGill University, Canada	2.000000	0.18
Oregon Health and Science University (OHSU), United States of America (USA)	1.000000	0.09
University of Virginia (UVA), United States of America (USA)	1.000000	0.09
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)	1.000000	0.09
Diabetes and Endocrine Treatment Specialists, United States of America (USA)	1.000000	0.09

Interested in Health Services and Systems?